$2.41
-0.02-0.82%
At Close: -
$2.47
0.062.49%
After Hours: 7:03 PM EDT
15 minutes delayed
Checkpoint Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Checkpoint Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.18 | $-0.30 | 40.0 % |
Mar 2024 | 2024-05-10 | $-0.33 | $-0.27 | -22.2 % |
Dec 2023 | 2024-03-22 | $-1.10 | $-0.54 | -103.7 % |
Sep 2023 | 2023-11-13 | $-0.29 | $-0.72 | 59.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $41.00K | $20.00K | 105.0 % |
Mar 2024 | 2024-05-10 | $0 | $10.00K | -100.0 % |
Dec 2023 | 2024-03-22 | $6.00K | $20.00K | -70.0 % |
Sep 2023 | 2023-11-13 | $31.00K | $10.00K | 210.0 % |
Checkpoint Therapeutics (CKPT) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.18, which beat the estimate of $-0.30.
The Actual Revenue was $41K, which beat the estimate of $20K.
Browse earnings estimates, EPS, and revenue on all stocks.